Cleared Special

K233407 - AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip (LAA0) (FDA 510(k) Clearance)

Also includes:
AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip (ACH1) AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip (ACH2) AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip (PRO1) AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip (PRO2) AtriClip PRO-V LAA Exclusion System (PROV) AtriClip Flex-V LAA Exclusion System with preloaded V Clip (ACHV)
Nov 2023
Decision
28d
Days
Class 2
Risk

K233407 is an FDA 510(k) clearance for the AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip (LAA0). This device is classified as a Left Atrial Appendage Clip, Implantable (Class II - Special Controls, product code PZX).

Submitted by AtriCure, Inc. (Mason, US). The FDA issued a Cleared decision on November 2, 2023, 28 days after receiving the submission on October 5, 2023.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 878.4300. Intended To Occlude The Left Atrial Appendage..

Submission Details

510(k) Number K233407 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 05, 2023
Decision Date November 02, 2023
Days to Decision 28 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code PZX — Left Atrial Appendage Clip, Implantable
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4300
Definition Intended To Occlude The Left Atrial Appendage.